UPDATE 2-Mylan defends King deal amid investor concerns Generic drug maker Mylan Laboratories Inc. reaffirmed on Wednesday its planned \$3.37 billion purchase of King Pharmaceuticals Inc. 
Is this a piece of news regarding world politics, sports, business, or science and technology? 